Chinese medical experts have confirmed that Chloroquine Phosphate, an antimalarial drug, has a certain curative effect on coronavirus, according to Xinhuanet.
Read Also: Imo Woman Cuts Husband’s Nose, Tongue, Calls Mother To Evacuate His Corpse
Sun Yanrong, the deputy head of the China National Center for Biotechnology Development under the Ministry of Science and Technology, made this known during a press conference on Monday.
Based on the result of clinical trials, Chloroquine Phosphate, a well known antimalarial drug, has been confirmed to have certain curative effect on coronavirus disease, the Chinese official said.
The medical experts have “unanimously” suggested that the drug be included in the next version of the treatment guidelines and applied in wider clinical trials as soon as possible.
Chloroquine Phosphate, which has been used for more than 70 years to treat malaria, was selected from tens of thousands of existing drugs after multiple rounds of screening, Sun said.
Read Also: University Student Who Went Missing On Valentine’s Day Found Dead
According to her, the drug has been under clinical trials in over 10 hospitals in Beijing, as well as in south China’s Guangdong Province and central China’s Hunan Province, and has shown fairly good efficacy.
In the trials, the groups of patients that have taken the drug have shown better indicators than their parallel groups, in abatement of fever, improvement of CT images of lungs, the percentage of patients who became negative in viral nucleic acid tests and the time they need to do so, she said.
Patients taking the drug also take shorter time to recover, she added.
Sun gave an example of a 54-year-old patient in Beijing, who was admitted to hospital four days after showing symptoms. After taking the drug for a week, he saw all indicators improve and the nucleic acid turn negative.
Read Also: Three Die After Crane Falls During Movie Shoot
So far, no obvious serious adverse reactions related to the drug have been found among the over 100 patients enrolled in the clinical trials, she said.